EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Testing the Luedemann hypothesis: the discovery of novel antimicrobials from slow-growing microbes from nutrient-limited environments

Brendan Lin, Sunmin Woo iD, Alesa Philbrick, John Bacsa, Emily Laskey, Nancy Mehra, Vijay S Gondil iD, Jia A Mei, George Jones, Martin S Pavelka iD, Michelle Dziejman iD, Daniel A Shutter und 8 weitere

mSphere · 2025

DOI: 10.1128/msphere.00367-25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift mSphere, 2025. Verfasst von Brendan Lin und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, University of Rochester Medical Center, Rochester, New York, USA. Hauptthemen laut MEDLINE: Soil Microbiology, Anti-Bacterial Agents, Anti-Infective Agents, Bacteria. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCCIH NIH HHS, NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

George Luedemann is known throughout the antimicrobial community as one of the discoverers of the natural product antibiotic gentamicin. He subsequently hypothesized that slow-growing organisms inhabiting inhospitable, nutrient-limited environments may represent an enriched source of previously undescribed microbes that produce novel antimicrobials to create a competitive advantage over faster-growing rival organisms. Accordingly, 750 slow-growing microorganisms were isolated from desert rock surfaces and archived prior to Dr. Luedemann’s passing in 2000. Here, we describe the characterization and antimicrobial screening of the first 147 members of the Luedemann collection. 16S rRNA and whole-genome sequencing revealed that the pilot isolate set is highly diverse and includes novel microbial species belonging to genera commonly associated with soil samples, including Geodermatophilus , Streptomyces , and Micromonospora . Antimicrobial screening and comparative genomics indicate that at least six members are likely to produce novel antimicrobials with activity toward the ESKAPE pathogens, Vibrio cholerae and/or Mycobacterium smegmatis . Indeed, we show that the library member “9005BA” produces a newly identified phenazine, pyocyanin A, which displays potent (0.625 µg/mL), selective bactericidal activity toward Acinetobacter baumannii and efficacy in animals. Genetic and biochemical assays revealed that the antimicrobial activity of pyocyanin A is likely to be mediated by oxidative stress and can be overcome by altering bacterial respiration and/or efflux. Taken together, the data suggest that slow-growing organisms inhabiting nutrient-limited environments represent a previously overlooked rich source of microbial and antimicrobial agent diversity. IMPORTANCE The discovery and study of novel bacterial species offer an opportunity to identify new microbial biological processes, molecular mechanisms, and secondary metabolites, such as new antibiotics. Our work indicates that slow-growing organisms inhabiting nutrient-limited environments may represent an enriched source of novel microbial species. Furthermore, we find that a subset of these organisms is likely to produce corresponding novel antimicrobials, presumably as a means to outcompete faster-growing rival organisms. Indeed, we show that a putative new Streptomyces species is capable of producing a previously undescribed antimicrobial, pyocyanin A, with potent, selective antibacterial toward Acinetobacter baumannii , a prominent cause of antibiotic-resistant infections.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Soil MicrobiologyAnti-Bacterial AgentsAnti-Infective AgentsBacteriaRNA, Ribosomal, 16SPyocyaninePhylogenyMicrobial Sensitivity TestsWhole Genome SequencingNutrients

Stichwörter der Autor:innen

Acinetobacter baumanniiantimicrobialnatural product

Substanzen

RNA, Ribosomal, 16SAnti-Bacterial AgentsAnti-Infective AgentsPyocyanineNutrients

Autor:innen und Institutionen

  • Department of Microbiology and Immunology, University of Rochester Medical Center, Rochester, New York, USA.
  • Center for the Study of Human Health, Emory University College of Arts and Sciences, Atlanta, Georgia, USA.
  • Department of Chemistry, Emory University College of Arts and Sciences, Atlanta, Georgia, USA.
  • Department of Chemistry and Biochemistry, Notre Dame University, South Bend, Indiana, USA.
  • Perritt Laboratories, Hightstown, New Jersey, USA.
  • Department of Chemistry, North Carolina State University, Raleigh, North Carolina, USA.

ORCID-Profile: Sunmin Woo, Vijay S Gondil, Martin S Pavelka, Michelle Dziejman, Christian Melander, Yaoyao Shen, Wei-Chen Chang, Cassandra L Quave, Paul M Dunman

Förderung

  • NCCIH NIH HHS
  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Lin, B., Woo, S., Philbrick, A., Bacsa, J., Laskey, E., Mehra, N., Gondil, V. S., Mei, J. A., Jones, G., Pavelka, M. S., Dziejman, M., Shutter, D. A., Melander, C., Perritt, A. M., Jakober, R., Shen, Y., Chang, W. C., Quave, C. L., Dunman, P. M., & Luedemann, G. (2025). Testing the Luedemann hypothesis: the discovery of novel antimicrobials from slow-growing microbes from nutrient-limited environments. mSphere. https://doi.org/10.1128/msphere.00367-25

Vancouver

Lin B, Woo S, Philbrick A, Bacsa J, Laskey E, Mehra N, et al. Testing the Luedemann hypothesis: the discovery of novel antimicrobials from slow-growing microbes from nutrient-limited environments. mSphere. 2025. doi:10.1128/msphere.00367-25

BibTeX
@article{Lin2025,
  author = {Lin, Brendan and Woo, Sunmin and Philbrick, Alesa and Bacsa, John and Laskey, Emily and Mehra, Nancy and Gondil, Vijay S and Mei, Jia A and Jones, George and Pavelka, Martin S and Dziejman, Michelle and Shutter, Daniel A and Melander, Christian and Perritt, Alexander M and Jakober, Rick and Shen, Yaoyao and Chang, Wei-Chen and Quave, Cassandra L and Dunman, Paul M and Luedemann, George},
  title = {Testing the Luedemann hypothesis: the discovery of novel antimicrobials from slow-growing microbes from nutrient-limited environments},
  journal = {mSphere},
  year = {2025},
  doi = {10.1128/msphere.00367-25}
}
Kostenlos starten →